GMH HP Injection (Menotrophin) Used to Treat Male and Female Infertility

Name: GMH HP Injection (Menotrophin) Used to Treat Male and Female Infertility
Brand: Sun Pharma, India
SKU: G0110K
Availability: InStock
Rating: 5 (1 reviews)

Sold: 1 Orders Placed

In stock

SKU

G0110K

Rating:

100% of 100

1 Review Add Your Review

$0.00

GMH HP Injection (Menotrophin) is a medicine known as a sex hormone used to treat infertility in women who are not ovulating properly, male infertility, and male hypogonadism.

GMH HP 75IU Injection (Menotrophin)

Package	QTY	Price	Add To Cart
1 Injection/s		$24.63
3 Injection/s		$73.89
5 Injection/s		$123.15

GMH HP 150IU Injection (Menotrophin)

Package	QTY	Price	Add To Cart
1 Injection/s		$37.13
3 Injection/s		$111.39
5 Injection/s		$185.65

Qty

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Product Overview

GMH HP Injection is a highly purified human menopausal gonadotropin (hMG) containing Menotrophin. GMH HP Injection is an essential hormonal therapy used in reproductive medicine to treat infertility in both women and men. By providing a standardized combination of follicle-stimulating and luteinizing activities, it supplements or replaces the natural hormones required to trigger the reproductive process, facilitating follicular growth in the ovaries and supporting sperm development in the testes.

Product Composition

Active Ingredient: Menotrophin (Human Menopausal Gonadotropin)
Hormonal Ratio: 1:1 ratio of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) activity.
Formulation: Lyophilized (freeze-dried) powder for injection, supplied with a separate ampoule of sterile solvent (Sodium Chloride).
Common Strengths: 75 IU, 150 IU
Purity Status: Highly Purified (HP), ensuring low levels of non-specific proteins and high batch-to-batch consistency.

Product Specifications

Feature	Specification
Drug Category	Gonadotropin / Ovulation Inducer
Therapeutic Class	Infertility Management
Route of Administration	Subcutaneous (SC) or Intramuscular (IM)
Storage	Store at room temperature (below 25°C); protect from light

Mechanism of Action

Folliculogenesis Induction: In the female body, the FSH component of Menotrophin initiates the recruitment and growth of ovarian follicles. The LH component acts on the theca cells to promote the production of androgens, which are then converted into estrogens.
Endometrial Priming: By stimulating the production of estradiol within the developing follicles, it helps thicken the uterine lining, preparing it for the potential implantation of an embryo.
Gamete Maturation: It provides the necessary hormonal environment for the final stages of egg maturation before ovulation is triggered by other medications (like hCG).
Testicular Stimulation: In males with specific hormonal deficiencies, Menotrophin acts directly on the Sertoli cells within the testes to stimulate and maintain spermatogenesis (the production of healthy sperm).

Key Benefits

Dual Hormone Support: Unlike pure FSH preparations, the inclusion of LH activity is crucial for patients who have profound gonadotropin deficiencies and require both hormones for successful follicle development.
High Tolerability: The Highly Purified (HP) nature of the formulation reduces the risk of local skin reactions and discomfort at the injection site.
Predictable Response: Standardized bioactivity allows fertility specialists to precisely calibrate the dose to the patient's specific needs.
Proven Efficacy in ART: A reliable choice for complex Assisted Reproductive Technology procedures, helping to optimize the number and quality of oocytes (eggs) retrieved.
Versatile Application: Provides a vital therapeutic pathway for various endocrine-related fertility challenges in both genders.

Precautions

Medical supervision

Use GMH HP Injection (Menotrophin) only under strict medical supervision
Must be administered by a trained healthcare professional
Do not self-inject or adjust dosage on your own
Regular monitoring is essential during treatment

Health conditions

Condition	Precaution
Ovarian cysts	May require evaluation before use in women
Unexplained vaginal bleeding	Must be diagnosed before starting therapy
Testicular tumors	Must be ruled out in men
Thyroid/adrenal disorders	May affect treatment response
Severe systemic illness	Requires specialist evaluation

Ovarian hyperstimulation risk (women)

May cause OHSS (ovarian hyperstimulation syndrome)
Symptoms: abdominal pain, bloating, nausea, weight gain
Severe cases may include breathlessness or fluid buildup
Immediate medical care required if symptoms appear

Injection safety

Must be given using sterile technique only
Do not reuse needles or vials
Report pain, redness, or swelling at injection site

Monitoring advice

Regular ultrasound scans (women) and semen analysis (men) required
Hormone levels may be monitored frequently
Dose and timing must be strictly followed

Lifestyle precautions

Avoid alcohol and smoking during treatment
Maintain healthy diet and hydration
Avoid strenuous physical activity if ovaries are enlarged (women)

Fertility precautions

Multiple pregnancy risk in women (twins or more)
Treatment should be done only in controlled fertility programs (e.g., IVF)
Do not use without fertility specialist guidance

Warning signs

Severe abdominal pain, vomiting, or breathing difficulty
Sudden swelling or rapid weight gain
Severe injection site reactions
Seek immediate medical attention if these occur

Usage

GMH HP Injection is a specialized medication that requires administration under the guidance of a physician experienced in fertility treatment. Because it stimulates the reproductive organs directly, precise timing and clinical monitoring are essential to achieve the desired therapeutic outcome.

Dosage and Administration

Following the established injection protocol and monitoring schedule is critical for safety and success.

Administration Route: This injection is administered either Subcutaneously (SC) or Intramuscularly (IM). Subcutaneous injection in the abdominal area is often preferred for self-administration due to ease and comfort.
Preparation: Reconstitute the lyophilized powder only when you are ready to use it. Use the sterile solvent provided. Gently swirl the vial until the powder is completely dissolved; do not shake the vial vigorously.
Administration Timing: Injections should be given at the same time each day. For women, the treatment cycle usually begins within the first few days of the menstrual period.
Monitoring Protocol: Throughout the treatment, the patient must undergo regular transvaginal ultrasounds and blood tests (to measure estradiol levels). This allows the physician to monitor follicle growth and adjust the dose as needed.
Triggering Ovulation: When the follicles reach an optimal size (usually determined via ultrasound), a final injection of Human Chorionic Gonadotropin (hCG) is typically administered to induce the final release of the egg.
Storage and Disposal: The reconstituted solution must be used immediately. Any remaining liquid should be discarded. Always use a new sterile syringe and needle for every injection.
Safety Precaution: If signs of Ovarian Hyperstimulation Syndrome (OHSS) occur—such as severe pelvic pain, bloating, or nausea—contact your specialist immediately.
Missed Dose: If a dose is missed, do not double the next dose. Contact your fertility clinic immediately for guidance on how to adjust your schedule.

Uses

GMH HP Injection is indicated for the treatment of various hormonal and reproductive conditions in both women and men.

Primary Therapeutic Uses

Ovulation Induction: Indicated for women who are not ovulating or have irregular cycles, including those with Polycystic Ovary Syndrome (PCOS), who have not responded to simpler treatments.
Controlled Ovarian Hyperstimulation (COH): A primary component of Assisted Reproductive Technologies (ART) such as In Vitro Fertilization (IVF), used to stimulate the development of multiple follicles for egg retrieval.
Management of Hypogonadotropic Hypogonadism: Used in women with severe deficiencies in FSH and LH to restore the hormonal signals necessary for ovarian function.
Stimulation of Spermatogenesis: In men with hormonal deficiencies, it is used to stimulate the testes to produce healthy sperm, often as part of a long-term treatment plan combined with hCG.
Treatment of Luteal Phase Deficiency: Occasionally used to support the corpus luteum, ensuring adequate progesterone production to maintain the uterine lining for pregnancy.
Development of Secondary Sexual Characteristics: In specific cases of delayed puberty due to hypogonadism, it can be used to initiate the hormonal processes associated with reproductive maturity.

Side effects

Common side effects

Abdominal pain or pelvic discomfort
Bloating
Nausea
Headache
Injection site pain, redness, or swelling
Mild weight gain

Hormonal and reproductive effects

Ovarian enlargement (in women)
Multiple follicle development
Breast tenderness
Mood changes

General effects

Fatigue
Dizziness
Mild fever or body ache (less common)

Digestive system effects

Vomiting
Stomach upset
Loss of appetite

Serious side effects (rare)

Serious effect	Possible signs
Ovarian hyperstimulation syndrome (OHSS)	Severe abdominal pain, rapid weight gain, bloating, breathlessness
Severe allergic reaction	Rash, swelling, difficulty breathing
Fluid accumulation	Swelling in abdomen or legs
Severe pelvic pain	Persistent or worsening pain
Multiple pregnancy (risk)	Twins or more in pregnancy

Important warning

Seek immediate medical attention if severe abdominal pain, breathlessness, or rapid weight gain occurs
Regular ultrasound and hormone monitoring are essential during treatment
Report any unusual or worsening symptoms promptly to your fertility specialist

FAQs

Q: What is GMH HP Injection used for?

A: GMH HP Injection is used to treat infertility in both men and women. In women, it stimulates egg development and ovulation. In men, it improves sperm count and treats male hypogonadism and delayed puberty.

Q: How does GMH HP Injection work?

A: In women, Menotrophin stimulates the growth and maturation of egg follicles in the ovaries, increases oestrogen levels, and promotes proliferation of the endometrium, leading to the release of a mature egg. In men, it stimulates sperm production by acting on the seminiferous tubules of the testes and increases testosterone levels.

Q: How is GMH HP Injection administered?

A: GMH HP Injection is given as an injection under the skin or into a muscle by a doctor or nurse. Do not self-administer this medicine.

Q: How long does treatment with GMH HP Injection last?

A: In women, the duration of treatment depends on the ovarian response, which is monitored regularly by the doctor through oestrogen level tests and ultrasound. In men, treatment duration is decided by the doctor based on sperm count and hormonal response.

Q: What are the common side effects of GMH HP Injection?

A: Common side effects include stomach pain or swelling, nausea, headache, fatigue, dizziness, depression, restlessness, and injection site reactions such as pain, redness, and swelling. Most are mild and resolve on their own. Consult your doctor if they persist or worsen.

Q: What is ovarian hyperstimulation syndrome (OHSS)?

A: OHSS is a serious but rare complication of fertility treatment where the ovaries respond too strongly to the hormone injections. Symptoms include severe stomach pain, bloating, nausea, vomiting, and shortness of breath. Seek immediate medical attention if you experience any of these symptoms during treatment.

Q: Who should not take GMH HP Injection?

A: Avoid if you are allergic to Menotrophin or any of its ingredients. Also avoid if you have tumours of the breast, uterus, testes, prostate, pituitary gland or hypothalamus, polycystic ovarian disease with enlarged ovaries, heavy vaginal bleeding, high blood prolactin levels, thyroid or adrenal gland problems, or fibroids in the uterus.

Q: Can GMH HP Injection be used during pregnancy?

A: No, GMH HP Injection should not be used during pregnancy. Inform your doctor immediately if you become pregnant during treatment.

Q: Is GMH HP Injection safe during breastfeeding?

A: Consult your doctor before taking GMH HP Injection while breastfeeding as its safety during breastfeeding has not been fully established.

Q: Can GMH HP Injection be used in children?

A: GMH HP Injection is not intended for use in children and adolescents below 18 years of age. Consult your doctor before using it in this age group.

Q: Can GMH HP Injection be used in women with polycystic ovarian disease (PCOD)?

A: Yes, GMH HP Injection can be used in women with PCOD who are not responding adequately to other medicines such as clomiphene citrate. However, it is not recommended in patients with polycystic ovarian disease with enlarged ovaries. Close monitoring is required during treatment.

Q: Can GMH HP Injection increase the chance of multiple pregnancies?

A: Yes, fertility treatments with gonadotropins such as Menotrophin carry a higher risk of multiple pregnancies such as twins or triplets. Your doctor will monitor your response to treatment carefully to minimise this risk.